Similar articles

• Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.

  Horowitz JD, Lang WJ, Howes LG, Fennessy MR, Christophidis N, Rand MJ, Louis WJ. Horowitz JD, et al. Lancet. 1980 Jan 12;1(8159):60-1. doi: 10.1016/s0140-6736(80)90490-0. Lancet. 1980. PMID: 6153233 Clinical Trial.
• Phenylpropanolamine and blood pressure: a review of prospective studies.

  Morgan JP, Funderburk FR. Morgan JP, et al. Am J Clin Nutr. 1992 Jan;55(1 Suppl):206S-210S. doi: 10.1093/ajcn/55.1.206s. Am J Clin Nutr. 1992. PMID: 1728835 Review.
• Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.

  Graf P, Toll K, Palm J, Hallén H. Graf P, et al. Acta Otolaryngol. 1999;119(7):837-42. doi: 10.1080/00016489950180513. Acta Otolaryngol. 1999. PMID: 10687944 Clinical Trial.
• Phenylpropanolamine and hemorrhagic stroke.

  Ernst ME, Hartz A. Ernst ME, et al. N Engl J Med. 2001 Apr 5;344(14):1094; author reply 1095. N Engl J Med. 2001. PMID: 11291667 No abstract available.
• Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.

  Mersfelder TL. Mersfelder TL. Cleve Clin J Med. 2001 Mar;68(3):208-9, 213-9, 223. doi: 10.3949/ccjm.68.3.208. Cleve Clin J Med. 2001. PMID: 11263849 Review.